- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about EXEL
Recent news which mentions EXEL
2 Top Biotech Stocks to Buy for the Long Haul
October 28, 2022
From Motley Fool
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
From Benzinga
The Smartest Stocks to Buy With $20 Right Now
October 14, 2022
From Motley Fool
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
From InvestorPlace
From Motley Fool
3 Biotech Stocks to Buy and Hold for the Next 10 Years
September 28, 2022
From Motley Fool
2 No-Brainer Biotech Stocks to Buy Right Now
September 26, 2022
From Motley Fool
3 Monster Stocks in the Making
September 24, 2022
From Motley Fool
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
From InvestorPlace
2 Growth Stocks That Could Double in the Next Year
September 19, 2022
From Motley Fool
Exelixis' XL092/ Atezolizumab Shows Encouraging Efficacy, Safety In Heavily Pretreated Cancer Patients
September 12, 2022
Tickers
EXEL
From Benzinga
Exelixis Announces Detailed Results From Late-Stage Cabometyx Combo Trial In Kidney Cancer
September 08, 2022
Tickers
EXEL
From Benzinga
From Motley Fool
2 No-Brainer Bio-Tech Stocks to Buy Right Now
August 13, 2022
From Motley Fool
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
2 Top Biotech Stocks Defying the Bear Market
August 06, 2022
From Motley Fool
From Motley Fool
3 Stocks That Are Fantastic Deals Right Now
July 28, 2022
From Motley Fool
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
From InvestorPlace
2 Biotech Stocks to Help Recession-Proof Your Portfolio
July 22, 2022
From Motley Fool
1 Reason to Buy Exelixis Stock, and 1 Reason to Sell
July 22, 2022
From Motley Fool
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
From InvestorPlace
From Benzinga
3 Beaten-Down Growth Stocks to Buy Now and Hold Forever
July 01, 2022
From Motley Fool
2 Biotech Stocks That Could Make You Richer
June 26, 2022
From Motley Fool
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.